These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30603638)

  • 1. Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.
    Yang ZF; Wu DQ; Wang JJ; Feng XY; Zheng JB; Hu WX; Li Y
    Ann Transl Med; 2018 Dec; 6(23):450. PubMed ID: 30603638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Efficacy Between Transabdominal and Transthoracic Surgical Approaches for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis.
    Li Z; Jiang H; Chen J; Jiang Y; Liu Y; Xu L
    Front Oncol; 2022; 12():813242. PubMed ID: 35574358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study.
    Zhang W; Chen X; Liu K; Yang K; Chen X; Zhao Y; Zhao Y; Chen J; Chen L; Hu J
    Chin J Cancer Res; 2016 Aug; 28(4):413-22. PubMed ID: 27647969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole.
    Huang Y; Liu G; Wang X; Zhang Y; Zou G; Zhao Z; Cao Z; Zhao H; Yuan X; Zhang C
    World J Surg Oncol; 2021 Mar; 19(1):73. PubMed ID: 33714262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Choice of surgical approach for Siewert II and III adenocarcinomas of the esophagogastric junction].
    Zhang X; Yang J; Ping H; Zuo H; Yang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Sep; 17(9):924-6. PubMed ID: 25273665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
    Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
    J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
    Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
    Front Oncol; 2021; 11():748694. PubMed ID: 34926257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
    Zheng H; Yin X; Pan T; Tao X; Xu X; Li Z
    BMC Cancer; 2023 Nov; 23(1):1130. PubMed ID: 37990193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures.
    Duan XF; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
    Medicine (Baltimore); 2017 Feb; 96(7):e6120. PubMed ID: 28207537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma.
    Peng J; Wang WP; Yuan Y; Hu Y; Wang Y; Chen LQ
    Ann Thorac Surg; 2015 Jul; 100(1):263-9. PubMed ID: 25980597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.